- Why are vegetarians more likely to suffer from depression than meat eaters?
- Small wireless device implanted between skin and skull helps kill cancer cells
- Will the mRNA vaccine that can cure cancer come out near soon?
- Allogeneic T-cell therapy set for landmark first approval
- Boston University denies that the new COVID strain they made has 80% fatality rate
- A new generation of virus-free CAR-T cell therapy
FDA: Johnson & Johnson COVID-19 vaccine may cause neurological diseases
FDA: Johnson & Johnson COVID-19 vaccine may cause neurological diseases. According to the US “New York Times” report, on July 12, the US Food and Drug Administration (FDA) issued another warning about Johnson & Johnson’s vaccine, saying that it may cause a rare neurological disease, Guillain-Barre syndrome.
This is the second time the agency has issued a warning against Johnson & Johnson vaccine. In April this year, the Food and Drug Administration warned that Johnson & Johnson’s vaccine may increase the risk of blood clots in vaccinators.
According to reports, Guillain-Barré syndrome is a rare neurological disease, the most serious of which can lead to paralysis. Earlier, Guillain-Barré syndrome was also found to be related to flu vaccines, such as the swine flu vaccine in 1976.
According to people familiar with the matter, regulators have found that the risk of Guillain-Barre syndrome among those vaccinated by Johnson & Johnson is three to five times that of the general population. The U.S. Centers for Disease Control and Prevention (CDC) stated in a statement that about 100 initial reports of Guillain-Barré syndrome have been reported among people receiving Johnson & Johnson’s COVID-19 pneumonia vaccine, and 95% of the cases are more serious. Need to be hospitalized.
At present, 12.8 million people in the United States have been vaccinated by Johnson & Johnson, accounting for about 8% of the population in the United States who have been vaccinated.
This is the second time the Food and Drug Administration has issued a warning against Johnson & Johnson vaccine. In April of this year, the agency warned that the Johnson & Johnson vaccine may increase the risk of blood clots in vaccinators. On the 9th of this month, the European Medicines Agency listed capillary leak syndrome as another side effect of the Johnson & Johnson vaccine, and said that it is not recommended for people with rare blood disorders.
(source:internet, reference only)